WuXi Webinar “Demystifying Product Development in China” Attracts Big Audience

We held the complimentary webinar to offer insights into working in China, an operating environment that has remained a mystery to many despite its status as one of the industry’s most...

WuXi PharmaTech Corporate Venture Fund Participates in Syros $30M Series A

Syros Pharmaceuticals, a new startup company based in greater Boston area, raised $30 million funding in April 2013, which was led by ARCH Venture Partners and Flagship Ventures. Syros will use...

World-Class Scientists Lecture at WuXi

Chi-Huey Wong, PhD President, Academia Sinica Professor, Scripps Research Institute Lecture Title Advances in Glycoscience: Interplay of Chemistry and Biology Dec 6, 2012 Richard Ulevitch, PhD Venture Partner, 5AM Ventures Professor, Scripps Research Institute Lecture Title Systems Guided Forward Genetics as ...

WuXiPRA Officially Starts Operations

We are very pleased to announce that WuXiPRA Clinical Research Co., Ltd., officially began its operations on May 28, 2013. This joint venture brings together PRA's global clinical trial expertise and...

WuXi Receives Merck Awards for Achieving Team Milestones

Four WuXi medicinal chemistry teams received Merck Awards in May 2013 “in recognition of the team's outstanding efforts to achieve a milestone”. It gives us great pleasure to contribute to Merck's...

SPOTLIGHT

STAY CONNECTED

Twitter LinkedIn 

INNOVATION THAT MATTERS

Inside Perspectives: NuMedii Banking on Artificial Intelligence to Expedite the Discovery...

One company in the artificial intelligence (AI) space, Menlo Park, Calif.-based NuMedii, has been pioneering the use of big data, AI and systems biology...